Abstract

Rates of invasive aspergillosis (IA) among COVID-19 ICU patients seem to reach over 30% in certain settings. At Vienna General Hospital (VGH), all rooms in COVID-19 ICUs were put under negative pressure as a protective measure, thus increasing the risk of exposure to environmental pathogens for patients. Even though all ICU patients are surveilled for healthcare-associated infections (HAI), there were concerns that the routine protocol might not be sufficient for IA detection. We reviewed the electronic patient charts of all patients with COVID-19 admitted to ICUs between 1 March 2020 and 31 July 2021 for fungal co- or superinfections, comparing four diagnostic algorithms based on different recommendations for the diagnosis of IA (according to EORTC/MSG, BM-AspICU, IAPA and CAPA) to our routine surveillance protocol. We found that out of 252 patients who were admitted to the ICU during the study period, 25 (9.9%) fulfilled the criteria of probable or possible IA of at least one algorithm. The IAPA definitions detected 25 and the CAPA definition 23 probable and 2 possible cases, out of which only 16 were classified as hospital-acquired IA by routine surveillance. In conclusion, adjustment of the routine protocol using a classification system especially designed for respiratory viral illness seems useful for the surveillance of IA in a highly vulnerable patient cohort.

Highlights

  • Rates of invasive aspergillosis (IA) among COVID-19 ICU patients seem to reach over 30% in certain settings

  • Even though all ICU patients are surveilled for healthcare-associated infections (HAI), there were concerns that the routine protocol might not be sufficient for IA detection

  • We reviewed the electronic patient charts of all patients with COVID-19 admitted to ICUs between 1 March 2020 and 31 July 2021 for fungal co- or superinfections, comparing four diagnostic algorithms based on different recommendations for the diagnosis of IA to our routine surveillance protocol

Read more

Summary

Introduction

Invasive aspergillosis (IA), which is most commonly caused by Aspergillus fumigatus [1–3], is a well-known complication in patients with hematological malignancies or bone marrow transplantation due to severe neutropenia [4,5]. It occurs in patients with severe respiratory conditions needing high-dose corticosteroid or other immunomodulating treatment [3]. Reports on IA rates among COVID-19 ICU patients vary, some authors have reported rates of over 30% [6,7]. Several factors seem to lead to the increased susceptibility of COVID-19 patients to IA, i.e., ARDS, prolonged hospital/ICU stay, prolonged mechanical ventilation and/or extracorporeal membrane oxygenation (ECMO) and therapy with corticosteroids [10]. The Centers for Disease Prevention and Control (CDC) recommend increased awareness regarding IA in

Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call